Bernhard Hemmer
- Pathology and Forensic Medicine top 0.02%
- Multiple Sclerosis Research Studies 199
- Immunology top 0.1%
- Immunotherapy and Immune Responses 76
- T-cell and B-cell Immunology 57
- Neurology top 0.1%
- Peripheral Neuropathies and Disorders 58
- Neuroinflammation and Neurodegeneration Mechanisms 23
- Neurology top 0.1%
- Peripheral Neuropathies and Disorders 58
- Neuroinflammation and Neurodegeneration Mechanisms 23
- Developmental Neuroscience top 0.5%
-
- Systemic Lupus Erythematosus Research 43
-
- Monoclonal and Polyclonal Antibodies Research 32
-
- Polyomavirus and related diseases 31
Bernhard Hemmer
344 papers receiving 19.8k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Pathology and Forensic Medicine 9.5k
- Immunology 6.9k
- Neurology 2.5k
- Neurology 4.4k
- Developmental Neuroscience 692
Countries citing papers authored by Bernhard Hemmer
This map shows the geographic impact of Bernhard Hemmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Hemmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Hemmer more than expected).
Fields of papers citing papers by Bernhard Hemmer
This network shows the impact of papers produced by Bernhard Hemmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Hemmer. The network helps show where Bernhard Hemmer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bernhard Hemmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 33 | |
| 10 | 2022 | 17 | |
| 11 | 2021 | 25 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 22 | |
| 14 | 2019 | 78 | |
| 15 | 2018 | 81 | |
| 16 | Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis - results of the placebo-controlled, double-blind, Phase III ORATORIO study | 2015 | 36 |
| 17 | 2014 | 20 | |
| 18 | 2013 | 137 | |
| 19 | 2010 | 67 | |
| 20 | 2008 | 101 |
About Bernhard Hemmer
Bernhard Hemmer is a scholar working on Pathology and Forensic Medicine, Immunology, Neurology, Rheumatology and Neurology, having authored 354 papers that have together received 20.1k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (199 papers), Immunotherapy and Immune Responses (76 papers), Peripheral Neuropathies and Disorders (58 papers), T-cell and B-cell Immunology (57 papers), Systemic Lupus Erythematosus Research (43 papers), Monoclonal and Polyclonal Antibodies Research (32 papers), Polyomavirus and related diseases (31 papers) and Neuroinflammation and Neurodegeneration Mechanisms (23 papers). The work is most often cited by research in Pathology and Forensic Medicine (9.5k citations), Immunology (6.9k citations), Neurology (2.5k citations), Neurology (4.4k citations) and Developmental Neuroscience (692 citations). Bernhard Hemmer has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Sabine Cepok, Hans‐Peter Hartung, Thomas Korn, Roland Martinꝉ, Achim Berthele, Olaf Stüve, Stefan Nessler, Jeroen J.G. Geurts, Marco Vergelli and Olga Ciccarelli. Their work appears in journals such as Multiple Sclerosis Journal, Neurology, Journal of Neuroimmunology, Annals of Neurology and Journal of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.